Haleon HLN
NYSE HLN
$9.88 +0.01 (+0.05%)
At close: Aug 20, 2026 · 2:04 PM UTC

Haleon (HLN) Total Debt Growth (3y) (2024 - 2026)

Haleon (HLN) Total Debt Growth (3y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - 15.43%
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn -7.08%
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 11.33%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -3.67%
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -10.43%
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn -
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn -13.72%
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - 92.83%
10 Alkermes 8.11 Bn 7.46 Bn 397.90 Mn 72.66%

Historic Data

Download Data
DateValue
Jun 30, 2026 4.20%
Dec 31, 2025 -40.25%
Dec 31, 2024 287.28%